• Given the opportunities for profits for entrenched players in the US healthcare system, we expected a SaaS player with incredible datasets to be one of these.
• Despite continuously increasing these datasets and the functionality of the platform, the company isn’t thriving financially.
• Not even the transition to SaaS has done the trick, but we don’t exclude it will in the future.

Source: Inovalon Got It All To Show – Inovalon (NASDAQ:INOV) | Seeking Alpha